Litigation Details for United States v. Cytogel Pharma, LLC (E.D. La. 2016)
✉ Email this page to a colleague
United States v. Cytogel Pharma, LLC (E.D. La. 2016)
Docket | ⤷ Try a Trial | Date Filed | 2016-08-19 |
Court | District Court, E.D. Louisiana | Date Terminated | 2018-11-27 |
Cause | 28:2201 Declaratory Judgment | Assigned To | Donna Sue Morgan |
Jury Demand | None | Referred To | Janis Van Meerveld |
Patents | 6,011,062 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in United States v. Cytogel Pharma, LLC
Details for United States v. Cytogel Pharma, LLC (E.D. La. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-10-25 | 395 | Order on Motion to Dismiss | 3d 1099, 1110, writ denied, 2011-0636 (La. 5/6/11), 62 So. 3d 127. 94 R. Doc. 279. 95 R. Doc. 220 at …obtained two patents, U.S. Patent Nos. 5,885,958 (“the ’958 Patent”) and 6,303,578 (“the ’578 Patent”), claiming…Cyt-1010 is covered by the ’958 Patent, the ’587 Patent, or both patents. 12 R. Doc. 1 at 5, 6, ¶ 16, 20…published patent application, like a patent, is readily available – the United States Patent and Trademark…’436 Patent to Tulane nor his using the ’958 at ’578 Patent compounds to develop the ’436 Patent constitute | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |